Literature DB >> 20942834

Bladder regeneration in a canine model using hyaluronic acid-poly(lactic-co-glycolic-acid) nanoparticle modified porcine small intestinal submucosa.

Christopher C Roth1, Fadee G Mondalek, Yusuf Kibar, Richard A Ashley, Cardin H Bell, John A Califano, Sundar V Madihally, Dominic Frimberger, Hsueh-Kung Lin, Bradley P Kropp.   

Abstract

OBJECTIVE: • To determine if hyaluronic acid (HA) can be incorporated into porcine small intestinal submucosa (SIS) through poly (lactide-co-glycolide-acid) (PLGA) nanoparticles to improve the consistency of the naturally derived biomaterial and promote bladder tissue regeneration.
METHODS:Beagle dogs were subjected to 40% partial cystectomy followed by bladder augmentation with commercial SIS or HA-PLGA-modified SIS. • Urodynamic testing was performed before and after augmentation to assess bladder volume. • A scoring system was created to evaluate gross and histological presentations of regenerative bladders.
RESULTS: • All dogs showed full-thickness bladder regeneration. • Histological assessment showed improved smooth muscle regeneration in the HA-PLGA-modified SIS group. • For both groups of dogs, urodynamics and graft measurements showed an approximate 40% reduction in bladder capacity and graft size from pre-augmentation to post-regeneration measurements. • Application of the scoring system and statistical analysis failed to show a significant difference between the groups.
CONCLUSIONS: • SIS can be modified through the addition of HA-PLGA nanoparticles. The modified grafts showed evidence of improved smooth muscle regeneration on histological assessment, although this difference was not evident on a novel grading scale. • The volume loss and graft shrinkage experienced are consistent with previous models of SIS bladder regeneration at the 10-week time point. • Additional research into the delivery of HA and the long-term benefits of HA on bladder regeneration is needed to determine the full benefit of HA-PLGA-modified SIS. In addition, a more objective biochemical characterization will be needed to evaluate the quality of regeneration.
© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20942834     DOI: 10.1111/j.1464-410X.2010.09757.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  17 in total

1.  Temporal expression of hyaluronic acid and hyaluronic acid receptors in a porcine small intestinal submucosa-augmented rat bladder regeneration model.

Authors:  Fadee G Mondalek; Kar-Ming Fung; Qing Yang; Weijuan Wu; Wenli Lu; Blake W Palmer; Dominic C Frimberger; Beverley Greenwood-Van Meerveld; Robert E Hurst; Bradley P Kropp; Huesh-Kung Lin
Journal:  World J Urol       Date:  2014-09-25       Impact factor: 4.226

Review 2.  Bladder biomechanics and the use of scaffolds for regenerative medicine in the urinary bladder.

Authors:  Fatemeh Ajalloueian; Greg Lemon; Jöns Hilborn; Ioannis S Chronakis; Magdalena Fossum
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

Review 3.  Dynamic reciprocity in cell-scaffold interactions.

Authors:  Joshua R Mauney; Rosalyn M Adam
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

4.  Inosculation of blood vessels allows early perfusion and vitality of bladder grafts--implications for bioengineered bladder wall.

Authors:  Stephanie L Osborn; Michelle So; Shannon Hambro; Jan A Nolta; Eric A Kurzrock
Journal:  Tissue Eng Part A       Date:  2015-04-22       Impact factor: 3.845

5.  Advances in biomimetic regeneration of elastic matrix structures.

Authors:  Balakrishnan Sivaraman; Chris A Bashur; Anand Ramamurthi
Journal:  Drug Deliv Transl Res       Date:  2012-10       Impact factor: 4.617

6.  Augmentation Cystoplasty of Diseased Porcine Bladders with Bi-Layer Silk Fibroin Grafts.

Authors:  Saif Affas; Frank-Mattias Schäfer; Khalid Algarrahi; Vivian Cristofaro; Maryrose P Sullivan; Xuehui Yang; Kyle Costa; Bryan Sack; Mehrnaz Gharaee-Kermani; Jill A Macoska; Gokhan Gundogdu; Catherine Seager; Carlos R Estrada; Joshua R Mauney
Journal:  Tissue Eng Part A       Date:  2018-10-26       Impact factor: 3.845

7.  The use of regenerative medicine in the management of invasive bladder cancer.

Authors:  Matthew E Hyndman; Deborah Kaye; Nicholas C Field; Keith A Lawson; Norm D Smith; Gary D Steinberg; Mark P Schoenberg; Trinity J Bivalacqua
Journal:  Adv Urol       Date:  2012-08-27

8.  Human Urine-derived Stem Cells Seeded Surface Modified Composite Scaffold Grafts for Bladder Reconstruction in a Rat Model.

Authors:  Jun Nyung Lee; So Young Chun; Hyo-Jung Lee; Yu-Jin Jang; Seock Hwan Choi; Dae Hwan Kim; Se Heang Oh; Phil Hyun Song; Jin Ho Lee; Jong Kun Kim; Tae Gyun Kwon
Journal:  J Korean Med Sci       Date:  2015-11-30       Impact factor: 2.153

9.  Bone marrow derived cells facilitate urinary bladder regeneration by attenuating tissue inflammatory responses.

Authors:  Matthew I Bury; Natalie J Fuller; Linnea Wethekam; Arun K Sharma
Journal:  Cent European J Urol       Date:  2015-01-24

Review 10.  Tissue engineering in animal models for urinary diversion: a systematic review.

Authors:  Marije Sloff; Rob de Vries; Paul Geutjes; Joanna IntHout; Merel Ritskes-Hoitinga; Egbert Oosterwijk; Wout Feitz
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.